Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Heitjan

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Artificial Intelligence in Medicine|November 12, 2021
PSA-Net: Deep learning-based physician style-aware segmentation network for postoperative prostate cancer clinical target volumesAnjali Balagopal, Howard Morgan, Michael Dohopolski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 4, 2012
Reproducibility of the nicotine metabolite ratio in cigarette smokersGideon St Helen, Maria Novalen, Daniel F Heitjan, et al.
Annals of the American Thoracic Society|November 19, 2013
Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusionsDaniel E Schwed Lustgarten, Jeffrey Thompson, Gordon Yu, et al.
Cancer Medicine|June 30, 2021
Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancerSandi L Pruitt, David E Gerber, Hong Zhu, et al.
Drug and Alcohol Dependence|June 11, 2008
A placebo-controlled trial of modafinil for nicotine dependenceRobert A Schnoll, E Paul Wileyto, Angela Pinto, et al.
NMR in Biomedicine|June 30, 2012
(31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalanKavindra Nath, David S Nelson, Andrew M Ho, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2015
Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resectionOlugbenga T Okusanya, Elizabeth M DeJesus, Jack X Jiang, et al.
The Lancet. Respiratory Medicine|January 16, 2015
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trialCaryn Lerman, Robert A Schnoll, Larry W Hawk, et al.
Leukemia & Lymphoma|June 7, 2006
A predictive model for the detection of tumor lysis syndrome during AML induction therapyAnthony R Mato, Brett E Riccio, Li Qin, et al.
Plos One|May 27, 2015
Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline SmokingRachel F Tyndale, Andy Z X Zhu, Tony P George, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Artificial Intelligence in Medicine|November 12, 2021
PSA-Net: Deep learning-based physician style-aware segmentation network for postoperative prostate cancer clinical target volumesAnjali Balagopal, Howard Morgan, Michael Dohopolski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 4, 2012
Reproducibility of the nicotine metabolite ratio in cigarette smokersGideon St Helen, Maria Novalen, Daniel F Heitjan, et al.
Annals of the American Thoracic Society|November 19, 2013
Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusionsDaniel E Schwed Lustgarten, Jeffrey Thompson, Gordon Yu, et al.
Cancer Medicine|June 30, 2021
Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancerSandi L Pruitt, David E Gerber, Hong Zhu, et al.
Drug and Alcohol Dependence|June 11, 2008
A placebo-controlled trial of modafinil for nicotine dependenceRobert A Schnoll, E Paul Wileyto, Angela Pinto, et al.
NMR in Biomedicine|June 30, 2012
(31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalanKavindra Nath, David S Nelson, Andrew M Ho, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2015
Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resectionOlugbenga T Okusanya, Elizabeth M DeJesus, Jack X Jiang, et al.
The Lancet. Respiratory Medicine|January 16, 2015
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trialCaryn Lerman, Robert A Schnoll, Larry W Hawk, et al.
Leukemia & Lymphoma|June 7, 2006
A predictive model for the detection of tumor lysis syndrome during AML induction therapyAnthony R Mato, Brett E Riccio, Li Qin, et al.
Plos One|May 27, 2015
Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline SmokingRachel F Tyndale, Andy Z X Zhu, Tony P George, et al.
Pageof 13